Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.
合理选择单克隆α-突触核蛋白抗体amlenetug（Lu AF82422）用于治疗α-突触核蛋白病
期刊:Npj Parkinsons Disease
影响因子:8.2
doi:10.1038/s41531-024-00849-1
Kallunki Pekka, Sotty Florence, Willén Katarina, Lubas Michal, David Laurent, Ambjørn Malene, Bergström Ann-Louise, Buur Louise, Malik Ibrahim, Nyegaard Steffen, Eriksen Thomas Thiilmark, Krogh Berit O, Stavenhagen Jeffrey B, Andersen Kathrine J, Pedersen Lars Ã, Cholak Ersoy, van den Brink Edward N, Rademaker Rik, Vink Tom, Satijn David, Parren Paul W H I, Christensen Søren, Olsen Line R, Søderberg Josefine N, Vergo Sandra, Jensen Allan, Egebjerg Jan, Wulff-Larsen Pernille Gry, Harndahl Mikkel N, Damlund Dina S M, Bjerregaard-Andersen Kaare, Fog Karina
